Mydecine Innovations Group Inc (CSE: MYCO) (OTC: MYCOF) (FSE: 0NF), a Canada-based life sciences company, has named former Red Bull marketing executive, Jim Gunning, as its new chief marketing officer, it was reported on Friday.
Gunning has over two decades of experience in marketing. He has served as the managing director of RESQWATER and as a consultant for Blue Sky Biologicals.
In the new role, Gunning will be responsible for helping Mydecine to become a household name, and for developing a marketing campaign around the company's new fungtional mushroom product range under Mydecine Health Sciences, the company's operational branch. The fungtional mushroom product line should be on retail shelves across the US before the end of this year.
EDX Medical to provide molecular profiling services to Astron Health
Futura Medical appoints Market Performance Group as new US distribution partner for Eroxon
MaaT Pharma to seek review after CHMP negative opinion on MaaT013 application
Sensei Biotherapeutics changes name to Faeth Therapeutics
Datavault AI and Wellgistics Health plan DelivMeds AI healthcare venture
Intensity Therapeutics receives Cancer Treatment Technology Innovator of the Year award
Solvonis Therapeutics appoints Water Tower Research to strengthen US market positioning
Atrium Therapeutics announces inducement grants to seven new employees